Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Healing Hope International Multinational Observational Registry Evaluating Intranasal 15-Gene AAV9-PHP.eB Therapy and Functional Outcomes in Participants With Cerebral Palsy & Chronic Hypoxic-Ischemic Encephalopathy (HIE) (GEN-HOPE Study)

NCT07264166 is registered in ClinicalTrials.gov with Healing Hope International as lead sponsor.

NCT NCT07264166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07264166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Healing Hope International Multinational Observational Registry Evaluating Intranasal 15-Gene AAV9-PHP.eB Therapy and Functional Outcomes in Participants With Cerebral Palsy & Chronic Hypoxic-Ischemic Encephalopathy (HIE) (GEN-HOPE Study)
Lead sponsor
Healing Hope International
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 1, 2026
Completion date
June 15, 2032
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, cerebral palsy (cp), cerebral palsy hemiparetic cerebral palsy spasticity gait disorders, neurologic postural balance impairment, cerebral palsy quadriplegic, cerebral palsy spastic diplegia, hypoxic brain damage, hypoxic ischaemic encephalopathy (hie), hypoxic ischaemic encephalopathy due to cardiac arrest, hypoxic ischemic encephalopathy of newborn